SMALES KELLY sold 0.6% of their position (471.00 shares) of TRANSPHORM, INC. on the open market
Open‑market sale worth $2.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/26/2024ACC: 0001209191-24-002296
-471.00
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
471.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−471.00
Price / share
$4.82
Trade value
$2.27K
% of position
0.6%
1/24/2024
78.03K→77.55K
Total
Net shares
−471.00
Net value
-$2.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/24/2024 | S · Sale | −471.00 | $4.82 | $2.27K | 0.6% | 78.03K | 77.55K |
| Total | −471.00 | -$2.27K | ||||||
Derivative Transactions0
No derivative transactions reported